Shield Therapeutics’ $26m Debt and Equity Fundraising

Taylor Wessing advised Shield Therapeutics on securing $26 million debt and equity fundraising.Shield Therapeutics plc, a specialty pharmaceutical company listed on AIM, has secured a $20…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Georgio Naffaa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here